OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 04:27:15 2024-06-06 EDT | ||
| 2.76 EUR | +0.36% |
|
| Current month | +6.59% | ||
| 1 month | +19.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 2.76 | +0.36% |
| 24-06-05 | 2.75 | +4.17% |
| 24-06-04 | 2.64 | 0.00% |
| 24-06-03 | 2.64 | +2.33% |
| 24-05-31 | 2.58 | +7.50% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 04:27 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG2F14 |
| ISIN | DE000GG2F143 |
| Date issued | 2024-01-11 |
| Strike | 113.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.49 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3 € |
|---|---|
| Lowest since issue | 1.25 € |
| Spread | 0.05 € |
| Spread % | 1.79% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142.7
USD
Average target price
147
USD
Spread / Average Target
+3.02%
- Stock Market
- Certificates
- Certificat
